soliris

This US Pharma Company Is Pissed Canada Wants It To Lower Its $700K-a-Year Drug

Connecticut-based Alexion Pharmaceuticals has submitted a motion to Canada’s Federal Court alleging the government has no authority over the cost of Soliris, which treats two rare blood diseases.